chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Fatigue, Headache, Pain
Clinical narrative: Headache; body aches; fatigue; low grade fever; SOB; This is a spontaneous report from a contactable physician (patient). A 38-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 09Jun2021 (age at vaccination 38 years old) at 14:45 as dose 1, single for COVID-19 immunization administered in hospital.Medical history included migraine, PCOS from an unknown date and unknown if ongoing. Concomitant medication included topiramate (TOPAMAX); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); thiamine hydrochloride (B1); cyanocobalamin (B12-VITAMIIN); escitalopram oxalate (LEXAPRO); beta-carotene, bioflavonoids nos, biotin, calcium ascorbate, calcium pantothenate, calcium phosphate, choline bitartrate, chromic chloride, cholecalciferol, copper sulfate, cyanocobalamin, folic acid, hesperidin, inositol, iron amino acid chelate, lycopene, lysine hydrochloride, magnesium oxide, manganese sulfate, molybdenum trioxide, nicotinamide, phytomenadione, potassium iodide, potassium sulfate, pyridoxine hydrochloride, retinol acetate, riboflavin, selenomethionine, silicon dioxide, colloidal, sodium borate decahydrate, thiamine mononitrate, tocopheryl acid succinate, ubidecarenone, zinc oxide (MULTIVITAMIN & MINERAL) taken for an unspecified indication, start and stop date were not reported. The patient previously took phenergan [promethazine] and experienced drug allergy (phenergan). The patient was not pregnant at the time of vaccination. On 10Jun2021 at 09:00, the patient experienced headache, body aches, fatigue, low grade fever, sob. The patient underwent lab tests and procedures which included fever: low grade on 10Jun2021 at 09:00. No other vaccine is administered in 4 weeks prior vaccination. No covid prior to vaccination and was not tested positive for covid post vaccination. No treatment was taken in response to the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; body aches; fatigue; low grade fever; SOB; This is a spontaneous report from a contactable physician (patient). A 38-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 09Jun2021 (age at vaccination 38 years old) at 14:45 as dose 1, single for COVID-19 immunization administered in hospital.Medical history included migraine, PCOS from an unknown date and unknown if ongoing. Concomitant medication included topiramate (TOPAMAX); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); thiamine hydrochloride (B1); cyanocobalamin (B12-VITAMIIN); escitalopram oxalate (LEXAPRO); beta-carotene, bioflavonoids nos, biotin, calcium ascorbate, calcium pantothenate, calcium phosphate, choline bitartrate, chromic chloride, cholecalciferol, copper sulfate, cyanocobalamin, folic acid, hesperidin, inositol, iron amino acid chelate, lycopene, lysine hydrochloride, magnesium oxide, manganese sulfate, molybdenum trioxide, nicotinamide, phytomenadione, potassium iodide, potassium sulfate, pyridoxine hydrochloride, retinol acetate, riboflavin, selenomethionine, silicon dioxide, colloidal, sodium borate decahydrate, thiamine mononitrate, tocopheryl acid succinate, ubidecarenone, zinc oxide (MULTIVITAMIN & MINERAL) taken for an unspecified indication, start and stop date were not reported. The patient previously took phenergan [promethazine] and experienced drug allergy (phenergan). The patient was not pregnant at the time of vaccination. On 10Jun2021 at 09:00, the patient experienced headache, body aches, fatigue, low grade fever, sob. The patient underwent lab tests and procedures which included fever: low grade on 10Jun2021 at 09:00. No other vaccine is administered in 4 weeks prior vaccination. No covid prior to vaccination and was not tested positive for covid post vaccination. No treatment was taken in response to the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pain in extremity
Clinical narrative: Muscle Pain; Joint Pain; Arm Pain; Tiredness; This is a spontaneous report from a contactable consumer (reported for himself). A 75-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EWO177/Batch number was not reported) via an unspecified route of administration, administered in left arm on 19May2021 (at the age of 75-year-old) as dose 1, single for COVID-19 immunization at other. Medical history included atrial fibrillation, myocardial infarction, chronic obstructive pulmonary disease, chronic kidney disease from, neuropathy peripheral, coronary artery disease and hypertension. Concomitant medication(s) included warfarin morphine, atorvastatin and amlodipine all the drugs taken for an unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received warfarin. On 20May2021, the patient experienced muscle pain, joint pain, arm pain and tiredness. No treatment was given for the events. The outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Inappropriate schedule of product administration, Nausea
Clinical narrative: Diarrhea; Headache; Nauseous; Second dose was administered before 19 days of primary dose; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Jun2021 at 16:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25May2021 at 16:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. On 09Jun2021, the patient experienced diarrhea, headache and nauseous. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, headache and nauseous was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-year-old (non-pregnant) female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# unknown, expiry date: not reported), via an unspecified route, in left arm, on May 25, 2021, at 15:00, single dose, for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications not reported. She has no known allergies or health issues. The patient did not receive any other vaccine within four weeks. Other medications within two weeks: none. On Jun 6, 2021, at 03:00, when she walked, she had severe pain in her left knee. She never had any knee pain. On the 15 day, now it was in her right knee. It felt like a band around her knee. When she bent down or got up from a sitting position, she had sharp pain. The sharp pain was only in the left knee. She has not yet gone to the doctor. No COVID-19 prior vaccination. No COVID-19 test post vaccination. Patient received no treatment for the event. The outcome of the events: not recovered. No follow-up attempts possible. No further information expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Period was over 2 weeks late; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient's period was over two weeks late. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event period was over two weeks late was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Fatigue, Heart rate
Clinical narrative: I felt tired/fatigue; I had increased heart rate/high pulse rate (about 120 the whole day); pain in my chest/I had chest pains around my heart; I had inflammation of my heart; Shortness of breath; my chest felt tight; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 17-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0176) via an unspecified route of administration, administered in arm left on 03May2021 14:00 (age at vaccination 17 years) as dose 2, single for COVID-19 immunization. Patient medical history included asthma (No longer a problem). Known allergies was reported as unknown. Family medical history relevant to adverse events was reported as mother A-fib, congestive heart failure. Other medications in two weeks was reported Non-Drowsy Allergy Relief 10 mg. The patient did not receive any other vaccine in four weeks. Covid prior vaccination was no and covid tested post vaccination was reported as no. Prior vaccinations was reported as none. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8734) via an unspecified route of administration, administered in arm left on 12Apr2021 14:00 as dose 1, single for COVID-19 immunization. It was reported that on 04May2021 06:00 he had increased heart rate, pain in his chest, his chest felt tight and he felt tired. All of these happened regardless of if I was actively doing something or sitting down relaxing. Due to the recent reports he believed he had inflammation of his heart but it only lasted about 24 hours, he had chest pains around his heart, shortness of breath, high pulse rate (about 120 the whole day) and fatigue on 04May2021 06:00. The patient underwent lab tests and procedures which included heart rate/pulse rate: about 120 on an unspecified date in 2021 (increased heart rate/high pulse rate (about 120 the whole day)). Seriousness of the events was reported as non serious. The patient did not receive any treatment for the adverse events. Relevant tests was none. The outcome of the events was recovered on 05May2021.  Follow-up attempts are completed. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Inflammation
Clinical narrative: I felt tired/fatigue; I had increased heart rate/high pulse rate (about 120 the whole day); pain in my chest/I had chest pains around my heart; I had inflammation of my heart; Shortness of breath; my chest felt tight; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 17-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0176) via an unspecified route of administration, administered in arm left on 03May2021 14:00 (age at vaccination 17 years) as dose 2, single for COVID-19 immunization. Patient medical history included asthma (No longer a problem). Known allergies was reported as unknown. Family medical history relevant to adverse events was reported as mother A-fib, congestive heart failure. Other medications in two weeks was reported Non-Drowsy Allergy Relief 10 mg. The patient did not receive any other vaccine in four weeks. Covid prior vaccination was no and covid tested post vaccination was reported as no. Prior vaccinations was reported as none. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8734) via an unspecified route of administration, administered in arm left on 12Apr2021 14:00 as dose 1, single for COVID-19 immunization. It was reported that on 04May2021 06:00 he had increased heart rate, pain in his chest, his chest felt tight and he felt tired. All of these happened regardless of if I was actively doing something or sitting down relaxing. Due to the recent reports he believed he had inflammation of his heart but it only lasted about 24 hours, he had chest pains around his heart, shortness of breath, high pulse rate (about 120 the whole day) and fatigue on 04May2021 06:00. The patient underwent lab tests and procedures which included heart rate/pulse rate: about 120 on an unspecified date in 2021 (increased heart rate/high pulse rate (about 120 the whole day)). Seriousness of the events was reported as non serious. The patient did not receive any treatment for the adverse events. Relevant tests was none. The outcome of the events was recovered on 05May2021.  Follow-up attempts are completed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Pyrexia, Tremor
Clinical narrative: Fever; Headaches; Body Shaking; Insomnia; This is a spontaneous report from a contactable consumer (Patient). A 24-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EW0217) via an unspecified route of administration in arm left on 10Jun2021 13:45 (age at the time of the vaccination 24 year) as dose 1, single for COVID-19 immunization. Medical history included COVID. No COVID tested post vaccination. Concomitant medications included gabapentin, clonidine and bupropion hydrochloride (WELLBUTRIN). On 10Jun2021 23:00, the patient experienced fever, headaches, body shaking and insomnia. No treatment received for the adverse events. On an unspecified date in 2021, the events recovered.   Follow-up attempts are completed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Period began a week early on 5/28 after receiving 2nd dose on 5/18; Currently 6/12 and period has not stopped. (Have been menstruating for 22 years and period is always 4-5 days.); This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18May2021 at 15:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Apr2021 at 15:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 28May2021, the patient had period which began a week early after receiving second dose. As on 12Jun2021, the period had not stopped. The patient had been menstruating for 22 years and period was always for 4-5 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period began a week early and period had not stopped were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 28-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 28, via an unspecified route of administration, in right arm, on Jun 12, 2021, at 11:30, single dose, for COVID-19 immunisation. Medical history included allergy to sulfa medication. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included vitamins received within 2 weeks of vaccination and unknown if ongoing. On Jun 13, 2021, patient experienced shortness of breath and cough when trying to take a big breath. The patient reported she does not leave house at all so it cannot be COVID-19. The events did not resulted in doctor/other healthcare professional office/clinic visit/emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of shortness of breath and cough when trying to take a big breath: not resolved (at the time of report). No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: low grade fever (99 F); Sore arms; Overall exhaustion; This is a spontaneous report from a contactable nurse. An (12-17 Years) adolescent female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, batch/lot number: EW0187), dose 2 intramuscular, administered in arm left on 12Jun2021 as dose 2, single for covid-19 immunization at Public Health Clinic/facility. The patient medical history and concomitant medications were not reported. Historical vaccine included received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, batch/lot number: EW0176), dose 1 Intramuscular, administered in arm left on 15May2021 as dose 1, single for covid-19 immunization. It was unknown whether the patient was pregnant. On 12Jun2021, the patient developed low grade fever (99 f), sore arms and had overall exhaustion. On 12Jun2021, the patient underwent lab tests and procedures which included low grade fever: 99 fahrenheit on 12Jun2021. The patient received Tylenol and ibuprofen as a treatment for the events. The outcome of events was recovered on an unspecified date in Jun2021.  Follow-up attempts are completed. No further information is expected.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Nasal congestion
Clinical narrative: Chest pain; Nasal congestion; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 10Jun2021 at 12:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and  known allergies were reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 20May2021 at 12:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. On 10Jun2021 at 19:00, the patient experienced chest pain and nasal congestion. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain and nasal congestion were resolved on an unknown date in Jun2021.   No follow-up attempts are possible. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Pain, Somnolence
Clinical narrative: mild shortness of breath; Chills; sleepiness; body aches; This is a spontaneous report from a contactable consumer. A 15-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: GW0191 and expiration date: not reported), via an unspecified route of administration on 13Jun2021 at 15:00 (at the age of 15-years-old) as dose number unknown, single for COVID-19 immunisation at pharmacy or drug store. The patient was not pregnant at the time of vaccination. The patient's medical history included hay fever and pollen allergies; from an unknown date and unknown if ongoing. Concomitant medication was not reported. No other vaccine in four weeks. On 14Jun2021, the patient experienced mild shortness of breath, chills, body aches and sleepiness. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. The outcome of events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches; fever; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 15-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0191) via an unspecified route of administration in the arm right (reported as right arm) on 14Jun2021 11:45 (at the age at vaccination of 15-year-old) as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with covid-19 and post the vaccination, the patient was not tested for covid-19. On 15Jun2021 13:00, patient experienced body aches and had a fever. Patient did not receive any treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Pain, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# and expiry date: not reported), via an unspecified route of administration, on Apr 7, 2021, single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# and expiry date: not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. The patient got second vaccine dose of yesterday (Apr 7, 2021); and today (Apr 8, 2021) he reported soreness in arm and shoulder area. Also, minor body aches and chills. The outcome of events: unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypoaesthesia
Clinical narrative: Face went numb and red (flushed); Face went numb and red (flushed); This is a spontaneous report from a contactable consumer (patient) reported for herself. A 48-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0178, Expiration date: unknown) via an unspecified route of administration, administered in left leg on 27May2021 at 12:30 pm (age at vaccination was 48 years) as dose 1, single for COVID-19 immunization. The patient's medical history included COVID-19. The patient had known allergies to one cough medicine. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 27May2021 at 17:30 pm, the patient's face went numb and red (flushed) about 5 hours after the shot. Lasted a few hours. No treatment was received for the adverse events. The outcome of the events was resolved on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Lymphadenopathy, Malaise
Clinical narrative: Injection site pain; tiredness; chills; fever; joint pain; feeling unwell; swollen lymph nodes; This is a spontaneous report from a contactable consumer (Patient). A 56-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0173, patient was not pregnant at the time of vaccination), via an unspecified route of administration on an unspecified date (at the age of 56-year-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. No covid prior vaccination, no Covid tested post vaccination. On 27May2021, the patient experienced injection site pain, tiredness, chills, fever, joint pain, feeling unwell, swollen lymph nodes. The outcomes of events were recovering.  No follow-up attempts are possible. No further information is expected.  Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; tiredness; chills; fever; joint pain; feeling unwell; swollen lymph nodes; This is a spontaneous report from a contactable consumer (Patient). A 56-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0173, patient was not pregnant at the time of vaccination), via an unspecified route of administration on an unspecified date (at the age of 56-year-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. No covid prior vaccination, no Covid tested post vaccination. On 27May2021, the patient experienced injection site pain, tiredness, chills, fever, joint pain, feeling unwell, swollen lymph nodes. The outcomes of events were recovering.  No follow-up attempts are possible. No further information is expected.  Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Dizziness, Headache, Hyperhidrosis
Clinical narrative: Headache; neck/shoulder tightening; slight eye focus; dizziness; chills; body aches; fever highest 99.4; sweating/claminess; sweating/claminess; shoulder tightening; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration, administered in left arm on 14Jun2021 at 11:30 (at the age of 54-year-old) (Batch/Lot Number: EW0168) as dose 1, single for covid-19 immunisation. Medical history included Charcoe Marie Tooth and Heart Disease-Stent. Concomitant medications included acetylsalicylic acid (ASPIRIN LOW) and Melatonin. The patient previously experienced known allergies for Bactroban [mupirocin], Minocycline and Penicillin. It was reported that patient experienced covid prior to vaccination. On 15Jun2021 the patient experienced headache, neck/shoulder tightening, slight eye focus, dizziness, chills, body aches, fever highest 99.4 and sweating/clamminess. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient had not been tested post vaccination for Covid. Patient did not receive treatment for events. The patient underwent lab tests and procedures which included pyrexia: highest 99.4 on 15Jun2021. Outcome of all the events recovered on unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Musculoskeletal stiffness, Ocular discomfort, Pain, Pyrexia
Clinical narrative: Headache; neck/shoulder tightening; slight eye focus; dizziness; chills; body aches; fever highest 99.4; sweating/claminess; sweating/claminess; shoulder tightening; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration, administered in left arm on 14Jun2021 at 11:30 (at the age of 54-year-old) (Batch/Lot Number: EW0168) as dose 1, single for covid-19 immunisation. Medical history included Charcoe Marie Tooth and Heart Disease-Stent. Concomitant medications included acetylsalicylic acid (ASPIRIN LOW) and Melatonin. The patient previously experienced known allergies for Bactroban [mupirocin], Minocycline and Penicillin. It was reported that patient experienced covid prior to vaccination. On 15Jun2021 the patient experienced headache, neck/shoulder tightening, slight eye focus, dizziness, chills, body aches, fever highest 99.4 and sweating/clamminess. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient had not been tested post vaccination for Covid. Patient did not receive treatment for events. The patient underwent lab tests and procedures which included pyrexia: highest 99.4 on 15Jun2021. Outcome of all the events recovered on unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Nausea, Pyrexia, Vomiting
Clinical narrative: fever; Swollen lymph nodes; chills; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 50-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0186) via an unspecified route of administration, administered in arm left on 13Jun2021 07:30 PM as DOSE 1, SINGLE for covid-19 immunisation (Pharmacy or Drug Store). Medical history included thrombocytopenia, allergies to penicillin, eggs, kiwi and covid-19 all from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen taken for an unspecified indication, start and stop date were not reported. Patient was not pregnant at time of vaccination and has not taken any other vaccines in four weeks. Patient has covid before vaccination and not been tested post vaccination. The patient experienced fever, swollen lymph nodes, chills, nausea and vomiting on 14Jun2021. Patient has not taken any treatments for the events. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Fluid retention
Clinical narrative: fluid retention in my fingers (both hands); fluid retention increased; PIP (proximal interphalangeal) pain (both hands) if I moved my fingers too quickly. Then came DIP (distal interphalangeal) pain (both hands) if I moved my fingers too quickly; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Batch/Lot Number: ER8734) via an unspecified route of administration on 05Apr2021 at 09:30 (at the age at vaccination of 64-year-old) in left arm as dose 2, single for covid-19 immunization. The patient's medical history and known allergies were reported as none. The patient had not received any concomitant medications including other medications within 2 weeks. Patient didn't receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with covid-19 and post-vaccination, the patient was not tested for covid-19. The patient previously received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Batch/Lot Number: EN6205) via an unspecified route of administration on 15Mar2021 at 09:30 (at the age at vaccination of 64-year-old) in left arm as dose 1, single for covid-19 immunization and experienced fluid retention in fingers (both hands) on 22Mar2021. His thumbs seem ok. Fluid retention first occurred about 1 week after first dose, but he did not associate it with the vaccine since he was expecting an immediate reaction (which he did not had), local pain at injection site (which he did not have) nor did he have other reported general symptoms. On an unspecified date in Apr2021, about a week after the second dose the patient experienced fluid retention increased, and patient started experiencing PIP (proximal interphalangeal) pain (both hands) if patient moved the fingers too quickly. Then came DIP (distal interphalangeal) pain (both hands) if patient moved the fingers too quickly. On 18May2021, patient discovered a website that said to contact patient's doctor if patient had swelling in patient's finger. He contacted the banner health nurse line on 19May2021 and reported the events. They advised him to see a doctor if he had red streaks in hands/arms or if hands felt hot. He reported that he did not. Currently he had fluid retention every morning when he woke up which somewhat subsides during the day. He was very concerned. The patient did not receive any treatment for the events. Outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: left arm pain; Fatigue; fever; headache; This is a spontaneous report from a contactable consumer or other non healthcare professional (patient). A 13-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EW0173, expiry date: not reported), via an unspecified route of administration in the left arm on 06Jun2021 08:00 (at the age of 13-years old) as dose 2, single for covid-19 immunisation. Medical history included juvenille arthritis and the patient previously received morphine and experienced allergies. Concomitant medications included adalimumab (HUMIRA) taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Post vaccination, the patient had not been tested for COVID-19. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EW0179, expiry date: not reported), via an unspecified route of administration in the left arm on 29May2021 9:30 as DOSE 1, SINGLE for covid-19 immunisation. On 16Jun2021 21:00, the patient experienced fatigue, left arm pain, fever, headache. No treatment was received for the events. The outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Fatigue, Heart rate, Palpitations
Clinical narrative: fever of around 100 degrees F; abnormal racing heart of 126 bpm; shortness of breath; fatigue; This is a spontaneous report from a contactable consumer (Patient's Parent). A 12-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162) via an unspecified route of administration, administered in Arm Right on 02Jun2021 at 13:45 (at the age of 12-year-old) as dose 2, single for COVID-19 immunisation. Medical history included atrial septal defect ASD level 1 from an unknown date and unknown if ongoing. There were no concomitant medications. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162) via an unspecified route of administration, administered in Arm Right on unknown date in May2021 (at the age of 12-year-old) as dose 1, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications in two weeks reported. On 03Jun2021 at 06:00 the patient experienced fever of around 100 degrees Fahrenheit, abnormal racing heart of 126 bpm, shortness of breath, fatigue. The patient underwent lab tests and procedures which included body temperature: 100 Fahrenheit, heart rate: 126 on 03Jun2021 (bpm abnormal racing). Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. Patient did not receive treatment for the events. Outcome of the events were resolved on unknown date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever of around 100 degrees F; abnormal racing heart of 126 bpm; shortness of breath; fatigue; This is a spontaneous report from a contactable consumer (Patient's Parent). A 12-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162) via an unspecified route of administration, administered in Arm Right on 02Jun2021 at 13:45 (at the age of 12-year-old) as dose 2, single for COVID-19 immunisation. Medical history included atrial septal defect ASD level 1 from an unknown date and unknown if ongoing. There were no concomitant medications. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0162) via an unspecified route of administration, administered in Arm Right on unknown date in May2021 (at the age of 12-year-old) as dose 1, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications in two weeks reported. On 03Jun2021 at 06:00 the patient experienced fever of around 100 degrees Fahrenheit, abnormal racing heart of 126 bpm, shortness of breath, fatigue. The patient underwent lab tests and procedures which included body temperature: 100 Fahrenheit, heart rate: 126 on 03Jun2021 (bpm abnormal racing). Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. Patient did not receive treatment for the events. Outcome of the events were resolved on unknown date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hot flush, Insomnia, Pyrexia
Clinical narrative: I'm trying to fall asleep; Hot flashes in hands and feet.; My hands and feet will start to feel really hot; My skin feels feverish to other people.; This is a spontaneous report from a contactable consumer (patient herself). A 18 years (non-pregnant) female received BNT162B2 (Pfizer BioNTech COVID 19 Batch/lot number: ER8733) via intramuscular route of administration in Left arm on 08Apr2021 at 12:15 PM as dose 1, single (age at time of vaccination 18 years) for covid 19 vaccination and received dose 2 of BNT162B2 (Pfizer BioNTech COVID 19 Batch/lot number: EW0161) via intramuscular route of administration in Left arm on 30Apr2021 at 16:45 PM as dose 2, single (age at time of vaccination 18 years) for covid 19 vaccination. The patient had allergies with sulfa drugs, amoxicillin. The medical history include endometriosis from unknown date if ongoing unknown. Patient received drug at Pharmacy or Drug Store. The patient had not diagnosed with covid prior to vaccination and had not tested post vaccination. The patient had not received any other vaccine in four weeks. Patient received Junel Fe Birth control pill, Ibuprofen in two weeks. On 13Apr2021 patient experienced Hot flashes in hands and feet. Several times a day, my hands and feet will start to feel really hot. No sweating. My skin feels feverish to other people. Sometimes it lasts hours, sometimes it lasts minutes. Patient experienced fall asleep. Hands and feet get miserably hot at random times during the day and night and vary greatly in duration over time. The hot flash will spread to the rest of me unless stopped by applying cold to wrists/ankles. More common when patient was trying to fall asleep, makes it difficult to stay outside in the heat for long periods. The patient received no treatment. The outcome of hot flashes in hands and feet, feels feverish, hands and feet will start to feel really hot were recovering while rest event was not recovered.  Follow-up attempts are completed. No further information is expected. This is case closure.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Numbness in hands; fatigue; muscle pain; joint pain; headache; fever (102.5 deg F); nausea; chills; This is a spontaneous report from a contactable consumer (Patient herself).  A 34-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: EW0183), via an unspecified route of administration, administered in Arm Left on 17Jun2021 10:30 (at the age of 34-years) as dose2, single for COVID-19 immunisation. Medical history included asthma, Known allergies: Allergic to ibuprofen, codeine, nuts, seeds, spices. Concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT); fluticasone furoate (AVAMYS); fexofenadine hydrochloride (ALLEGRA)- all taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: Lot number: EW0173), via an unspecified route of administration, administered in Arm Left on 27May2021 10:15 am as dose1, single for COVID-19 immunisation. On 17Jun2021 12:30, the patient experienced numbness in hands, fatigue, muscle pain, joint pain, headache, fever (102.5 deg F), nausea, chills. The patient underwent lab tests and procedures which included body temperature: 102.5 deg Fahrenheit on unspecified date. Treatment received with Tylenol as a result of events. The outcome of events was resolving.  Information on the lot/batch number has been requested.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Myalgia, Nausea, Pyrexia
Clinical narrative: Numbness in hands; fatigue; muscle pain; joint pain; headache; fever (102.5 deg F); nausea; chills; This is a spontaneous report from a contactable consumer (Patient herself).  A 34-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: EW0183), via an unspecified route of administration, administered in Arm Left on 17Jun2021 10:30 (at the age of 34-years) as dose2, single for COVID-19 immunisation. Medical history included asthma, Known allergies: Allergic to ibuprofen, codeine, nuts, seeds, spices. Concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT); fluticasone furoate (AVAMYS); fexofenadine hydrochloride (ALLEGRA)- all taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot Number: Lot number: EW0173), via an unspecified route of administration, administered in Arm Left on 27May2021 10:15 am as dose1, single for COVID-19 immunisation. On 17Jun2021 12:30, the patient experienced numbness in hands, fatigue, muscle pain, joint pain, headache, fever (102.5 deg F), nausea, chills. The patient underwent lab tests and procedures which included body temperature: 102.5 deg Fahrenheit on unspecified date. Treatment received with Tylenol as a result of events. The outcome of events was resolving.  Information on the lot/batch number has been requested.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.